|
|
|
|
 |
|
|
|
|
|
| |
| Vision & Mission |
| |
|
| |
Vision |
| |
The effective control of poverty-related infectious diseases in developing countries through the accelerated and sustainable introduction of new-generation vaccines. |
| |
|
| |
Mission |
| |
To combat infectious diseases through innovations in vaccine design, development and introduction, addressing the needs of people in developing countries.
|
| |
|
|
| |
| The IVI and the Millennium Development
Goals |
| |
| At the United Nations Millennium Summit in September
2000 world leaders placed development at the heart
of the global agenda by adopting the Millennium
Development Goals (MDGs), which set clear targets
for reducing poverty, hunger, disease, illiteracy,
environmental degradation, and discrimination against
women by 2015. The eight Millennium Development
Goals constitute an ambitious agenda to significantly
improve the human condition by 2015. The IVI is
actively working to make a valuable contribution
to achieving the MDGs. IVI's work supports the following
three MDGs: |
| |
| Millennium Development Goal 1, "Eradicate
extreme poverty and hunger". By preventing
unnecessary deaths and allowing people, especially
children, to lead healthy lives, the IVI contributes
to alleviating poverty and strengthening economies. |
| |
| Millennium Development Goal 4, "Reduce
child mortality". The research programs at
the IVI contribute to the target of reducing by
two-thirds, between 1990 and 2015, the under-five
mortality rate by addressing new-generation vaccines
against diarrhea and respiratory infections, and
against Japanese encephalitis and dengue fever.
Together these diseases claim the lives of nearly
five million persons each year, most of whom are
children living in impoverished conditions in developing
countries. |
| |
| Millennium Development Goal 6, "Combat HIV/AID, malaria and other diseases".
The research programs at the IVI contribute to the target of reducing by two-thirds, between 1990 and 2015, the under-five mortality rate by accelerating the introduction of new-generation vaccines against diarrhea and respiratory infections, and against Japanese encephalitis and dengue fever. Together these diseases claim the lives of over four million persons each year, most of whom are children living in impoverished conditions in developing countries. |
| |
| Millennium Development Goal 8, "Develop
a global partnership for development". The
mission of the IVI is to develop and accelerate
the introduction of new vaccines at affordable prices
into the public-health programs of developing countries.
The IVI facilitates transfer of vaccine technology
to pharmaceutical companies in developing countries
to create cost-effective vaccines for the world's
poor. The Institute also provides training and technical
assistance for the clinical evaluation of vaccines
and vaccine production and regulation to professionals
in developing countries. |
| |
| |
|
|
|
|
|